Fractyl Health Investor Relations Material
Latest events
Q4 2024
Fractyl Health
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Fractyl Health Inc
Access all reports
Fractyl Health Inc. is a healthcare biotechnology company dedicated to the development of innovative therapies for metabolic diseases, particularly type 2 diabetes (T2D) and obesity. The company's main therapeutic platforms include Revita DMR and Rejuva. Revita DMR is an outpatient procedural therapy aimed at modifying duodenal dysfunction—a condition influenced by a high-fat and high-sugar diet which can lead to T2D and obesity. Rejuva represents a novel gene therapy platform, delivered via adeno-associated virus, designed to achieve long-term remission of T2D and obesity by altering metabolic hormone function in pancreatic islet cells. The company is headquartered in Burlington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
GUTS
Country
🇺🇸 United States